Graphene oxide/chitosan |
Porous structure |
0.134 S m−1
|
Good cell viability, promotion of cell attachment and intercellular network formation, and upregulation of the cardiac‐specific gene and protein expression involved in muscle conduction of electrical signals (Connexin‐43) |
308
|
Graphene oxide/collagen |
Randomly oriented interconnected pores, 162 kPa tensile strength |
~10−4 S m−1
|
Supported neonatal CMs' adhesion and upregulated the expression of the cardiac genes, including Cx43, Actin4, and Trpt‐2 |
188
|
Polyethylene terephthalate/graphene oxide |
Electrospun core–shell nanofibers, a diameter of 253 ± 67 nm |
1.3 × 10−6 S cm−1
|
Supports human umbilical vein endothelial cells' spreading morphology and CM elongated morphology |
309
|
Hastalex (functionalised graphene oxide and poly[carbonate‐urea]urethane) |
Contact angles of Hastalex surfaces (85.2 ± 1.1°), tensile strength 57.1 MPa |
N/A |
No negative effect on the RBC membranes, a moderate macrophage infiltration had been detected |
310
|
Reduced graphene oxide foam templated by nickel foam |
organ‐on‐a‐chip engineering of cardiac constructs |
1.12 S cm−1
|
Good cell adherence, spreading, activity, organization, and beating function |
158
|
oligo(poly(ethylene glycol) fumarate)/graphene oxide |
Hydrogel, injectable |
4.235 × 10−3 S cm−1
|
Improve cell attachment, enhanced the Ca2+ signal conduction of CM in the infarcted region, enhanced the generation of cytoskeletal structure and intercalated disc assembly |
311
|